Beleodaq (belinostat) / Spectrum Pharma, Assertio, Valerio Therap, Aurobindo  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Beleodaq (belinostat) / Aurobindo, Assertio
NCT02137759: MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Active, not recruiting
2
29
US
Standard Radiation Therapy, Standard Temozolomide, Temodar, Belinostat, Beleodaq, PXD101
Emory University, Johns Hopkins University, Spectrum Pharmaceuticals, Inc, National Cancer Institute (NCI), National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)
Glioblastoma Multiforme of Brain
08/23
08/24
NCT02737046: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

Active, not recruiting
2
15
US
Belinostat, PXD101, Beleodaq®, Zidovudine, AZT, Interferon-Alfa-2b, IFN-α-2b, Pegylated Interferon-Alfa-2b, PEG-IFN-α-2b
University of Miami
Adult T-cell Leukemia-Lymphoma, ATLL
07/24
07/25
ETCTN, NCT04340843: Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

Active, not recruiting
2
32
US
Belinostat, Beleodaq, PXD 101, PXD-101, PXD101, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Decitabine and Cedazuridine, ASTX 727, ASTX-727, ASTX727, C-DEC, CDA Inhibitor E7727/Decitabine Combination Agent ASTX727, Cedazuridine/Decitabine Combination Agent ASTX727, Cedazuridine/Decitabine Tablet, DEC-C, Inaqovi, Inqovi, Guadecitabine, DNMT inhibitor SGI-110, S110, SGI 110, SGI-110, SGI110, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI
National Cancer Institute (NCI)
Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary Central Chondrosarcoma
01/25
01/25
NCT04747236: Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL

Recruiting
2
50
US
Azacytidine, Vidaza, Romidepsin, Istodax, Belinostat, Beleodaq, Pralatrexate, Folotyn, Gemcitabine, Gemzar
University of Virginia, Celgene
PTCL
06/26
06/28
NCT06406465: A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Not yet recruiting
2
60
US
Belinostat, Cisplatin, Etoposide
National Cancer Institute (NCI)
Carcinoma, Neuroendocrine, Tumor, Neuroendocrine, Tumors, Neuroendocrine, Neuroendocrine; Carcinoma, Small Cell; Receptors
07/27
07/28
NCT05170334: Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

Recruiting
2
32
US
Binimetinib, Mektovi, ARRY-162, Belinostat, Beleodaq
H. Lee Moffitt Cancer Center and Research Institute, Pfizer, Acrotech Biopharma Inc.
Metastatic Uveal Melanoma
12/24
12/24

Download Options